Viemed Healthcare, Inc. reported $302M of revenue over the trailing twelve months, +25% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $302M (to Q2 2026). Net income: $14M, trailing twelve months to Q2 2026. Free cash flow: $29M, trailing twelve months to Q2 2026. Operating margin: 7.6%, trailing twelve months to Q2 2026.

VMDViemed Healthcare, Inc.

Healthcare

$9.41+37% 1Y

$9.41

$6.2652 weeks$12.35

VMD as reported

Viemed Healthcare, Inc. reported $302M of revenue over the trailing twelve months, +25% on the year before. 11 reported series are charted on this page, each one as filed.

$302M

Revenue, trailing twelve months · to Q2 2026 · +25% against the twelve months before

Net income: $14M
Net income · +3.7% year on year · trailing twelve months to Q2 2026
Free cash flow: $29M
Free cash flow · −911% year on year · trailing twelve months to Q2 2026
Operating margin: 7.6%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for VMD, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$302M	+25%	Q2 2026
Net income	$14M	+3.7%	Q2 2026
EPS	$0.36	+2.9%	Q2 2026
Gross margin	57%	n/a	Q2 2026
Operating margin	7.6%	n/a	Q2 2026
Net margin	4.8%	n/a	Q2 2026
ROE	10%	n/a	Q2 2026
ROA	7.2%	n/a	Q2 2026
ROIC	13%	n/a	Q2 2026
Free cash flow	$29M	−911%	Q2 2026
P/E	26.1	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.